Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12

Authors: Beltran-Bless, Ana-Alicia, Clemons, Mark J., Fesl, Christian, Greil, Richard, Pond, Gregory R., Balic, Marija, Vandermeer, Lisa, Bjelic-Radisic, Vesna, Singer, Christian F., Steger, Guenther G., Helfgott, Ruth, Egle, Daniel, Sölkner, Lidija, Gampenrieder, Simon P., Kacerovsky-Strobl, Stephanie, Suppan, Christoph, Ritter, Magdalena, Rinnerthaler, Gabriel, Pfeiler, Georg, Fohler, Hannes, Hlauschek, Dominik, Hilton, John, Gnant, Michael

Source: European journal of cancer. 180:108-116

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100180271420.0x000001&indx=1&recIds=ETOCvdc_100180271420.0x000001

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

Authors: Eisen, Andrea, Somerfield, Mark R., Accordino, Melissa K., Blanchette, Phillip S., Clemons, Mark J., Dhesy-Thind, Sukhbinder, Dillmon, Melissa S., D'Oronzo, Stella, Fletcher, Glenn G., Frank, Elizabeth S., Hallmeyer, Sigrun, Makhoul, Issam, Moy, Beverly, Thawer, Alia, Wu, Joy Y., Van Poznak, Catherine H.

Source: Journal of clinical oncology. 40(7):787-800

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152379074.0x000001&indx=1&recIds=ETOCvdc_100152379074.0x000001

Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review

Authors: Ng, Terry L., Tu, Megan M., Ibrahim, Mohammed F. K., Basulaiman, Bassam, McGee, Sharon F., Srikanthan, Amirrtha, Fernandes, Ricardo, Vandermeer, Lisa, Stober, Carol, Sienkiewicz, Marta, Jeong, Ahwon, Saunders, Deanna, Awan, Arif A., Hutton, Brian, Clemons, Mark J.

Source: Supportive care in cancer. 29(2):925-943

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100192935940.0x000001&indx=1&recIds=ETOCvdc_100192935940.0x000001

Delivery of cancer care via an outpatient telephone support line: A cross-sectional study of oncology nursing perspectives on quality and challenges.

Authors: Shah, Hely, Vandermeer, Lisa, MacDonald, Fiona, Laroque, Gail, Nelson, Shannon, Clemons, Mark J., McGee, Sharon

Source: Journal of clinical oncology. 40(28 suppl):427-427

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100179132643.0x000001&indx=1&recIds=ETOCvdc_100179132643.0x000001

Lost in Transition? Thoughts on Retirement—'Will You Still Need Me, Will You Still Feed Me, When I'm Sixty‐Four?'

Authors: Clemons, Mark J., Vandermeer, Lisa A., Gunstone, Ian, Jacobs, Carmel, Kaizer, Leonard, Paterson, Alexander H.

Source: Oncologist. 18(11):1235-1238

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125881605.0x000001&indx=1&recIds=ETOCvdc_100125881605.0x000001

Bevacizumab for Advanced Breast Cancer: Hope, Hype, and Hundreds of Headlines

Authors: Fralick, Michael, Ray, Monali, Fung, Christina, Booth, Christopher M., Mallick, Ranjeeta, Clemons, Mark J.

Source: Oncologist. 18(11):1174-1179

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125881567.0x000001&indx=1&recIds=ETOCvdc_100125881567.0x000001

Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?

Authors: Freedman, Orit C., Amir, Eitan, Clemons, Mark J.

Source: In Critical Reviews in Oncology and Hematology 2009 72(1):56-64

A Randomized Clinical Trial of Adjuvant Chemotherapy for Radically Resected Locoregional Relapse of Breast Cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37

Authors: Wapnir, Irene L., Aebi, Stefan, Geyer, Charles E., Zahrieh, David, Gelber, Richard D., Anderson, Stewart J., Robidoux, André, Bernhard, Jürg, Maibach, Rudolf, Castiglione-Gertsch, Monica, Coates, Alan S., Piccart, Martine J., Clemons, Mark J., Costantino, Joseph P., Wolmark, Norman

Source: In Clinical Breast Cancer 2008 8(3):287-292

Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review.

Authors: Ng, Terry L., Tu, Megan M., Ibrahim, Mohammed F. K., Basulaiman, Bassam, McGee, Sharon F., Srikanthan, Amirrtha, Fernandes, Ricardo, Vandermeer, Lisa, Stober, Carol, Sienkiewicz, Marta, Jeong, Ahwon, Saunders, Deanna, Awan, Arif A., Hutton, Brian, Clemons, Mark J.

Source: Supportive Care in Cancer; 2021, Vol. 29 Issue 2, p925-943, 19p

Subject Terms: BONE metastasis, PROSTATE cancer, KIDNEY physiology, DENOSUMAB, OSTEONECROSIS, CASTRATION-resistant prostate cancer, CLINICAL trials, DIPHOSPHONATES, SYSTEMATIC reviews, RETROSPECTIVE studies, BONE tumors, QUALITY of life, BREAST tumors, PROSTATE tumors

This result is not displayed to guests.
Login for full access.

Do We Need More Hospices?

Authors: Clemons, Mark J., Kong, Wing May

Source: BMJ: British Medical Journal, 1993 Jul . 307(6897), 205-205.

Access URL: https://www.jstor.org/stable/29720435

Medicine: The Hearing Profession?

Authors: Clemons, Mark J., Clemons, Kate R., Skinner, Rod

Source: BMJ: British Medical Journal, 1992 Dec . 305(6868), 1568-1569.

Access URL: https://www.jstor.org/stable/29718017

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Systematic Review.

Authors: Dhesy-Thind, Sukhbinder, Fletcher, Glenn G., Blanchette, Phillip S., Clemons, Mark J., Gandhi, Sonal, Gupta, Rasna, Mates, Mihaela, Vandenberg, Ted

Source: Journal of Clinical Oncology; 6/20/2017, Vol. 35 Issue 18, following p1-61, 76p

This result is not displayed to guests.
Login for full access.

Evaluating response to interventions for vasomotor symptoms in patients with breast cancer: A patient-centered approach.

Authors: Cole, Katherine, McGee, Sharon, Clemons, Mark J., Liu, Michelle, MacDonald, Fiona, Vandermeer, Lisa, Ng, Terry L., Pond, Gregory Russell, El Emam, Khaled

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe24126-e24126, 1p

Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, Influence, CTS-5)? A TEAM Pathology substudy.

Authors: Beltran-Bless, Ana-Alicia, Pond, Gregory Russell, Bayani, Jane, Barker, Sarah, Spears, Melanie, Mallon, Elizabeth, Taylor, Karen J, Hasenburg, Annette, Markopoulos, Christos, Dirix, Luc Yves, Seynaeve, Caroline M., Van De Velde, Cornelis J.H., Rea, Daniel William, Vandermeer, Lisa, Hilton, John Frederick, Bartlett, John, Clemons, Mark J.

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p533-533, 1p

Can synthetic data accurately mimic oncology clinical trials?

Authors: El Kababji, Samer, Mitsakakis, Nicholas, Fang, Xi, Beltran-Bless, Ana-Alicia, Pond, Gregory Russell, Vandermeer, Lisa, Radhakrishnan, Dhenuka, Mosquera, Lucy, Clemons, Mark J., El Emam, Khaled

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p1554-1554, 1p